Dysregulation of m6A regulatory proteins has been noted in stomach cancer, exemplified by the upregulation of Methyltransferase-like 3 (METTL3), a critical m6A “writer,” in gastric cancer tissues, which has been associated with an unfavorable prognosis (Wei et al., 2022). This evidence concerns the gene METTL3 and gastric cancer.